Pagoclone Indevus.

Article Details

Citation

Bateson A

Pagoclone Indevus.

Curr Opin Investig Drugs. 2003 Jan;4(1):91-5.

PubMed ID
12625036 [ View in PubMed
]
Abstract

Pagoclone is a cyclopyrrolone GABAA receptor modulator under development by Indevus for the potential treatment of panic and anxiety disorders. Indevus initiated phase II/III trials in November 1996. Pfizer had initiated a phase III trial for panic disorder in August 2000 but discontinued development of the compound in June 2002.

DrugBank Data that Cites this Article

Drugs